It may, but only under very special circumstances.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells
British Journal of Cancer Open Access 30 September 2003
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gao, W., Han, F., Storm, C., Egan, W. & Cheng, Y.C. Phosphorothioate oligonucleotides are inhbitiors of human DNA polymerases and RNAse H: Implications for antisense technology. Mol. Pharmac. 41, 223–229 (1992).
Yakubov, L. et al. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J. Biol. Chem. 268, 18818–18823 (1993).
Stein, C.A., Cleary, A.M., Yakubov, L. & Lederman, S. Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus Type 1 gp120. Antisense Res. Devel. 3, 19–31 (1993).
Guvakova, M.A., Yakubov, L.A., Vlodavsky, I., Tonkinson, J.L. & Stein, C.A. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J. biol. Chem. 270, 2620–2627 (1995).
Simons, M., Edelman, E., DeKeyser, J., Langer, R. & Rosenberg, R. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67–70 (1992).
Burgess, T. et al. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is casued by a nonantisense mechanism. Proc. natn. Acad. Sci. U.S.A. 92, 4051–4055 (1995).
Lallier, T. and Bronner-Fraser, M. Inhibition of neural crest cell attachment by integrin antisense oligonucleotides. Science 259, 692–695 (1993).
Maltese, J., Sharma, H., Vassilev, L. & Narayanan, R. Sequence context of antisense RelA/NF-κB phosphorothioates determines specificity. Nucleic Acids Res. 23, 1146–1151 (1995).
Krieg, A. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549 (1995)
Tamamoto, T., Yamamoto, S., Kataoka, T. & Tokunaga, T. Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Res. Devel. 4, 119–122 (1994).
Yamamoto, S. et al. DNA from bacateria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immun. 36, 983–987 (1992).
Stein, C.A. & Krieg, A. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Devel. 4, 67–69 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stein, C. Does antisense exist?. Nat Med 1, 1119–1121 (1995). https://doi.org/10.1038/nm1195-1119
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1195-1119
This article is cited by
-
Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide
Cancer Immunology, Immunotherapy (2015)
-
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Nature Reviews Drug Discovery (2012)
-
Inhibition of granuloma‐associated angiogenesis by controlling mast cell mediator release: role of mast cell protease‐5
British Journal of Pharmacology (2005)
-
Hirudo medicinalis: A Platform for Investigating Genes in Neural Repair
Cellular and Molecular Neurobiology (2005)
-
Bcl-xL antisense oligonucleotides radiosensitise colon cancer cells
British Journal of Cancer (2003)